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Elevated Free Fatty Acids Induce Uncoupling
Protein 3 Expression in Muscle
A Potential Explanation for the Effect of Fasting
David S. Weigle, Leah E. Selfridge, Michael W. Schwartz, Randy J. Seeley, David E. Cummings, Peter J. Havel,
Joseph L. Kujjper, and Hector BeltrandelRio
The newly described uncoupling protein 3 (UCP3) may
make an important contribution to thermogenesis in
humans because of its high level of expression in skele-
tal muscle. Contrary to expectations, fasting, a condition
that reduces resting energy expenditure, has been
reported to increase UCP3 expression in muscle. We have
confirmed that a 10-fold increase in UCP3 mRNA levels
occurs in rat quadriceps muscle between 12 and 24 h of
food removal. A less consistent twofold increase in mus-
cle UCP2 mRNA levels was observed in animals fasted for
up to 72 h. Administration of recombinant leptin to pre-
vent a fall in circulating leptin levels did not eliminate the
fasting-induced increase in quadriceps UCP3 expression.
Administration of a high dose of glucocorticoid to fed ani-
mals to mimic the increase in corticosterone induced by
fasting did not reproduce the increase in UCP3 expression
observed in fasted animals. In contrast, elevation of cir-
culating free fatty acid levels in fed animals by Intralipid
plus heparin infusion caused significant increases in the
UCP3/actin mRNA ratio compared with saline-infused fed
controls in both extensor digitorum longus (2.01 ± 0.34
vs. 0.68 ± 0.11, P = 0.002) and soleus muscles (0.31 ± 0.07
vs. 0.09 ± 0.02, P - 0.014). We conclude that free fatty
acids are a potential mediator of the increase in muscle
UCP3 expression that occurs during fasting. This seem-
ingly paradoxical induction of UCP3 may be linked to
the use of free fatty acid as a fuel rather than an
increased need of the organism to dissipate energy.
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It has long been known that uncoupling protein 1(UCP1) is responsible for facultative thermogenesis inrodent brown adipose tissue under the control of thesympathetic nervous system (1). Newly described
members of this protein family, UCP2 and UCP3, have also
been shown to lower mitochondria! membrane potential
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when transfected into yeast (2-4), supporting the hypothesis
that these homologs also uncouple oxidative phosphorylation
and contribute to thermogenesis in vivo. UCP3 is of particu-
lar interest as a potential mediator of thermogenesis in
humans because it is expressed at a high level in human
skeletal muscle (5,6), a tissue that contributes significantly to
resting energy expenditure (7). Consistent with this hypoth-
esis, hypothyroidism in rats causes a reduction in muscle
UCP3 expression, whereas hyperthyroidism increases mus-
cle UCP3 expression relative to euthyroid animals (4). These
changes parallel the well-known effects of hypothyroidism
and hyperthyroidism on resting energy expenditure and
therefore support a physiological role for UCP3. In view of
these findings, the recent report that UCP3 (4), and possibly
UCP2 (4,8), mRNA expression in rat skeletal muscle increase
during fasting was unexpected, since fasting reduces energy
expenditure in animals and humans (9,10). In the present
study, we have confirmed that upregulation occurs and
assessed the relative changes in muscle UCP2 and UCP3
expression with fasting. We have also investigated the mech-
anism underlying this paradoxical result by examining the
impact on muscle UCP3 expression of leptin, glucocorti-
coids, and free fatty acids, circulating signals which help to
mediate the transition from the fed to the fasted state.
RESEARCH DESIGN AND METHODS
Animals. Male, 8- to 10-week-old Sprague-Dawley rats were caged at ther-
moneutrality on a 12:12 h light-dark cycle and given unrestricted access to stan-
dard rodent diet blocks (caloric density 4.05 kcal/g, Teklad, Madison, WI) and
water for at least 1 week prior to study according to one of the following pro-
tocols: i ) to examine the time course of UCP2 and UCP3 mRNA induction dur-
ing fasting, animals were caged in six groups of three animals each, standard diet
was removed at 0800 on day 1 of the experiment, and animals were weighed daily.
The three animals in each cage were decapitated at 0,6,12,24,48, or 72 h from
the beginning of the fast, and quadriceps muscle was flash-frozen for subsequent
RNA preparation. 2) To examine the effect of leptin on UCP3 induction during
fasting, six rats were given unrestricted access to standard diet and received daily
1 ml intraperitoneal injections of sterile 10 mmol/1 borate-buffered saline (BBS)
at 0800 and 1800. A second group of six rats was fasted beginning at 0800 on day
1 of the experiment and received identical twice-daily injections of BBS. A third
group of six rats was fasted beginning at 0800 on day 1 and received twice-daily
injections of recombinant human leptin (11) at a dose of 1 mg/kg in 1 ml of BBS.
Beginning 2 h after their 0800 injections on c. j 3, rats were decapitated in ran-
dom order for collection of trunk blood and quadriceps muscle. 3) To examine
the effect of glucocorticoids on UCP3 expression in fed animals, two control
groups of six rats each were given twice-daily subcutaneous injections of saline
at 0800 and 1800. One of these groups had unrestricted access to standard diet,
and the other was fasted beginning at 0800 on day 1 of the experiment. A third
group of six rats was fed ad libitum but received twice-daily subcutaneous injec-
tions of hydrocortisone sodium succinate (Upjohn, Kalamazoo, MI) at a dose of
50 mg/kg body wt. All rats were decapitated beginning at 1200 on day 2 for col-
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lection of quadriceps muscle. 4) To test the hypothesis that free fatty acids
induce UCP3 expression, jugular venous catheters were placed in three groups
of six rats each, tunneled subcutaneously to the interscapular region, and led
through a spring tether to a fluid swivel at the top of each cage. Catheters were
kept patent by infusion of sterile saline, and animals were allowed to recover from
surgery for 3 days, by which time their standard diet intakes had returned to base-
line. Saline infusions were continued in an ad libitum-fed control group and a
group that was fasted beginning at 0800 on day 1 of the experiment. The third
group of animals was fed ad libitum but received an infusion of 20% Intralipid
(Pharmacia, Clayton, NC) plus 50 U/ml heparin at a rate of 0.75 ml/h beginning
at 0800 on day 1 of the experiment. All rats were decapitated beginning at 1200
on day 2 for collection of trunk blood and soleus and extensor digitorum longus
(EDL) muscle. Plasma concentrations of free fatty acids and leptin were meas-
ured using kits supplied by Wako Diagnostics (Richmond, VA) and Linco
Research (St. Charles, MO), respectively. All procedures were approved by the
University of Washington Animal Care Committee.
Northern analysis. RNA was prepared by homogenizing tissues in a 10-fold vol-
ume excess of 4 mol/1 guanidinium isothiocyanate, sedimenting the RNA through
5.7 mol/1 cesium chloride, phenol chloroform extraction of RNA pellets, and
ethanol precipitation. RNA was quantified spectrophotometrically at 260 nm,
and the quality of preparations was verified by the detection of clear 28S and 18S
ribosomal RNA bands at a 2:1 intensity ratio on an ethidium-stained 0.8% agarose
gel. RNA was loaded at 15 pg per lane on a 0.8% agarose gel containing 37%
formaldehyde, and electrophoresis was performed at 75 volts for 3 h. RNA was
transferred to nylon membranes (Hybond-N, Amersham, Arlington Heights, IL)
overnight, crosslinked to membranes by ultraviolet irradiation, and prehybridized
for 1 h in ExpressHyb (Clontech) at 68°C. Blots were probed at 68°C with poly-
merase chain reaction-generated cDNA fragments of UCP or actin that were PP]-
labeled by random priming (Megaprime kit, Amersham), and washed at 55-68°C
in 0.25 x standard sodium citrate with 0.25% sodium dodecyl sulfate. The UCP2
probe was produced from positions 443 to 1022 of the published mouse sequence
(accession U69135), and the UCP3 probe was produced from positions 485 to 948
of the published human sequence (accession U84763). Hybridized blots were
placed in a Phosphorlmager cassette (Molecular Dynamics, Sunnyvale, CA) for
1-4 days, imaged, and quantified using Molecular Dynamics ImageQuant software.
Differences among groups were assessed by analysis of variance with post hoc
comparisons made using the Fisher PLSD test on StatView 4.5 software. Results
were considered statistically significant at the P < 0.05 level.
RESULTS
Experiment 1. The effect of a period of fasting of variable
duration on UCP2 and UCP3 mRNA levels in quadriceps, a
skeletal muscle composed of both fast-twitch and slow-
twitch fibers, is shown in Fig. 1. A 10-fold induction of UCP3
expression was detected between 12 and 24 h of food
removal. Although we also observed a significant increase in
UCP2 mRNA levels after 48 h of fasting (Fig. 1 and additional
data not shown), this effect tended to be inconsistent, with
the maximal increase being twofold above baseline.
Experiment 2. To test the hypothesis that the induction of
UCP3 expression in muscle by fasting resulted from a fall in
leptin levels, we performed Northern analysis on quadriceps
muscle from animals that were fed, fasted for 48 h, or fasted
for 48 h with leptin replacement. In vehicle-treated animals,
plasma leptin levels fell with fasting from 3.6 ± 0.6 to <0.5
ng/ml (P = 0.0002), whereas the mean level of human leptin
immunoreactivity, which was below the detectability of the
assay in the two vehicle-treated groups, was 48.1 ± 14.6 ng/ml
2 h after the last dose of human leptin in the fasted, leptin-
treated animals (P = 0.0013). As shown in Fig. 2, administra-
tion of leptin, even at a dose that produced supraphysiolog-
ical circulating levels, did not alter the highly significant
increase in muscle UCP3 mRNA content induced by fasting.
Experiment 3. To determine whether the induction of
UCP3 expression in muscle by fasting could be due to
increased glucocorticoid levels, we performed Northern
analysis on quadriceps muscle from animals that were fed, fed
with cortisol administration, or fasted for 28 h. As shown in
Duration of fast (h)
0 I 6 I 12 I 24 I 48 | 72
UCP2
UCP3
Actin
B
UCP2
60 80
Time (h)
FIG. 1. Induction of UCP2 and UCP3 expression during fasting. A: A
Northern blot of quadriceps muscle RNA from 18 rats was probed
with UCP2, UCP3, and actin cDNA fragments as described in the text.
B: Ratios of UCP/actin mRNA band intensity determined with a phos-
phorimager were plotted against duration of fasting (mean ± SE of
three rats per data point).
Fig. 3, administration of a pharmacological dose of hydro-
cortisone from the beginning of the 28-h interval produced no
increase in UCP3 mRNA levels, despite the significant
increase in UCP3 expression induced by a fast of the same
duration.
Experiment 4. To determine whether muscle UCP3 induction
varies according to fiber type, we compared the induction of
UCP3 expression by 28 h of fasting in a muscle composed
purely of fast-twitch glycolytic fibers (EDL) with the induction
observed in a muscle composed exclusively of slow-twitch
oxidative fibers (soleus). In EDL the UCP3/actin mRNA ratio
in fed vs. fasted animals was 0.68 ±0.11 vs. 2.44 ± 0.26 (P =
0.0002), and in soleus this ratio was 0.09 ± 0.02 vs. 0.28 ± 0.06
(P = 0.036). As shown in Fig. 4, elevation of circulating free
fatty acid levels by Intralipid plus heparin infusion in fed rats
resulted in a UCP3/actin ratio that was significantly greater in
both EDL (2.01 ± 0.34, P = 0.002) and soleus muscles (0.31 ±
0.07, P = 0.014) than that observed in fed saline-infused con-
trol animals. This increase in UCP3 expression did not differ
significantly from the increase induced by fasting in either mus-
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FIG. 2. Effect of leptin on fasting-induced UCP3 expression. A: A
Northern blot of quadriceps muscle RNA from 18 rats was probed
with UCP3 and actin cDNA fragments as described in the text. B:
Ratios of UCP3/actin mRNA band intensity were determined with a
phosphorimager. Bars represent the mean ± SE of six rats (P < 0.0001
for fasted and fast + leptin vs. fed, NS for fasted vs. fast + leptin).
cle type. Total energy intake (standard diet + Intralipid) in
experimental animals during the 28-h infusion was 99.9 ±7.7
kcal as compared with 90.7 ± 13.4 kcal in the fed saline-
infused control animals. The mean free fatty acid level in fed
animals was 0.26 ± 0.02 mmol/1 as compared with 0.54 ± 0.05
mmol/1 in fasted animals and 2.04 ± 0.23 mmol/1 in animals that
received infusions of Intralipid plus heparin.
DISCUSSION
Our data confirm that 24 h of fasting causes a large and repro-
ducible increase in UCP3 mRNA levels in skeletal muscle,
whereas a 12 h fast has no such effect. The absence of a fur-
ther increase in UCP3 expression between 24 and 72 h fol-
lowing food withdrawal suggests that the signal(s) mediating
this increase in gene expression reach a maximal level early
during the course of a fast. Although UCP2 mRNA levels also
tended to increase by 48 h of fasting, this effect was much less
striking and consistent than the induction of UCP3. The vari-
ability of the UCP2/actin mRNA ratio that we observed
between 12 and 72 h of fasting is consistent with conflicting
reports of the ability of fasting to induce UCP2 expression in
muscle (4,8). Substantial differences therefore appear to
exist in the metabolic factors regulating the expression of
UCP2 and UCP3 in muscle.
The transition from the fed to the fasted state is marked by
changes in a variety of circulating hormones and metabolic
substrates. Based on recent evidence that the fall in leptin lev-
els observed as early as 24 h after food withdrawal may coor-
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FIG. 3. Effect of hydrocortisone on UCP3 expression in fed animals.
A: A Northern blot of quadriceps muscle RNA from 18 rats was probed
with UCP3 and actin cDNA fragments as described in the text. B:
Ratios of UCP3/actin mRNA band intensity were determined with a
phosphorimager. Bars represent the mean ± SE of six rats (i* < 0.0001
for fed and fed + cortisol vs. fasted, NS for fed vs. fed + cortisol).
dinate a variety of neuroendocrine adaptations to fasting
(12), we hypothesized that leptin deficiency might also
explain the fasting-induced increase in UCP3 gene expression.
Our data clearly demonstrate that administration of leptin at
a dose that has been shown to affect both food intake and
reproductive function (13,14) did not prevent the induction
of UCP3 expression by fasting. This result is consistent with
recent reports that leptin may actually increase UCP2 (15) and
UCP3 (4) expression in adipose tissue and muscle of fed ani-
mals. Leptin seems unlikely to be a major regulator of UCP3
gene expression, however, since fasting leads to a signifi-
cant increase in muscle UCP3 mRNA levels, despite a
marked decrease in plasma leptin levels.
Circulating glucocorticoid levels increase in rats with as lit-
tle as 3 h of fasting (16) and are known to be potent regula-
tors of fuel metabolism and gene transcription. Although
corticosterone is the major glucocorticoid found in the
plasma of rats, hydrocortisone, triamcinolone, and dexa-
methasone are all biologically active in this species (17). We
found that administration of hydrocortisone at a dose that has
been reported to have a potent effect on gene transcription
(17) did not result in an increase in muscle UCP3 mRNA lev-
els in fed animals. Glucocorticoids therefore are unlikely
candidates to mediate the fasting-induced increase in UCP3
gene expression. This result conflicts with a recent report that
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FIG. 4. Effect of Intralipid + heparin infusion on UCP3 expression in
fed animals. A: Northern blots of EDL and soleus muscle from 18 rats
were each probed with UCP3 and actin cDNA fragments as described
in the text. B: Ratios of UCP3/actin mRNA band intensity were deter-
mined with a phosphorimager. Bars represent the mean ± SE of six rats
(EDL: P = 0.0021 for fed vs. fed + Intralipid, P = 0.0002 for fed vs.
fasted, NS for fed + Intralipid vs. fasted. Soleus: P = 0.0143 for fed vs.
fed + Intralipid, P = 0.0355 for fed vs. fasted, NS for fed + Intralipid
vs. fasted).
dexamethasone produced an increase in muscle UCP3
mRNA levels in mice 18 h after administration (4). However,
the latter report was based on injections given to only three
mice, and food intake data were not reported to confirm that
the increase attributed to glucocorticoid administration was
not actually due to stress-induced anorexia.
In the absence of ingested nutrients, the mobilization of
stored fat provides a major source of fuel to meet ongoing
energy requirements, especially in skeletal muscle. The onset
of lipolysis leads to a significant elevation in circulating free
fatty acid levels within 24 h of fasting, the interval over which
maximal induction of UCP3 gene expression occurs. The
similarity in the time course of these two events led us to
hypothesize that elevated free fatty acids represented a sig-
nal, important for the induction of UCP3 expression in mus-
cle. Our data provide direct support for this hypothesis, since
we found that the increase in UCP3 mRNA levels produced
by Intralipid infusion in fed animals was comparable to that
observed during fasting. It is noteworthy that elevation of cir-
culating free fatty acids produced similar increases in UCP3
gene expression in both EDL and soleus, muscles composed
of divergent fiber types that ordinarily derive energy from dif-
ferent fuel molecules. This observation suggests that the
effect of free fatty acids on UCP3 expression occurs in skele-
tal muscle throughout the body and could potentially have a
large impact on whole-body fuel utilization. It has recently
been reported that the 5' region of the UCP1 gene contains
a peroxisome proliferator-activated receptor y (PPAR-7)
response element and that PPAR-7 is involved in the differ-
entiation-dependent expression of UCP1 (18). Skeletal mus-
cle is now known to express PPAR-7 (19). The possible exis-
tence of a PPAR-7 response element in the UCP3 gene could
provide a mechanism by which free fatty acids, which are
ligands for PPAR-7, enhance UCP3 expression in muscle.
Plasma free fatty acid levels produced by Intralipid plus
heparin infusion in this study were higher than those
observed during fasting. The possibility must therefore be con-
sidered that an elevation of free fatty acids that precisely
matched that which occurred during fasting would have
resulted in a lesser induction of muscle UCP3. However, we
anticipate that smaller elevations of free fatty acids would still
be effective, since the widely used Intralipid plus heparin
protocol appears to be without nonspecific effects (20). Fur-
thermore, it is likely that the true circulating free fatty acid lev-
els in our experimental animals were lower than the measured
levels because of lipolysis that occurs in plasma samples
from heparin-treated animals in vitro (21). Future studies
using carefully defined infusions of individual free fatty acids
will be required to establish the precise dose-response rela-
tionship for UCP3 induction.
Our data may help to resolve the paradox that fasting
induces a potentially thermogenic protein in a tissue that
comprises a large fraction of body mass at a time when over-
all energy expenditure by the organism is known to be
decreased (9,10). We speculate that this induction of UCP3
may be linked to the utilization of free fatty acids as a fuel
rather than an increased need of the organism to dissipate
energy. This proposal is consistent with the ability of uncou-
pling proteins in the mitochondrial inner membrane to act as
retrograde anion transporters that could assist in the removal
of various charged species from the matrix of the mitochon-
dria (22). This function might be critical to preserve mito-
chondrial ionic or osmotic equilibrium in the face of the great
increase in fatty acid oxidation induced by fasting.
In summary, the striking induction of muscle UCP3 expres-
sion induced by fasting casts doubt on the role of this protein
as a mediator of increased thermogenesis. In addition to
measuring the impact of UCP3 on energy expenditure, future
studies should address the possibility that UCP3 plays a
direct role in the metabolism of free fatty acids by muscle dur-
ing fasting.
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